A B S T R A C T During the 1st hr after feeding folic acid-3H (3H-PteGlu) to fasting human volunteers, plasma S. faecalis and 3H activity were elevated to an equivalent degree, whereas after this, the 3H activity exceeded S. faecalis activity, which suggests gradual conversion of folic acid-8H to methyltetrahydrofolate-3H (5-CHsH4 PteGlu). The increase of L. casei activity exceeded the increase of S. faecalis and 3H activity, which is consistent with flushing of endogenous methyltetrahydrofolate from the tissues by the administered folic acid-3H.
produced a large increase of plasma L. casei activity and only a slight increase of S. faecalis and P. cerevisiae activity, which is consistent with very rapid conversion of folinic acid to methyltetrahydrofolate.
Bile folate concentration determined microbiologically was 2.3-9.8 times plasma folate. 40-80% of the bile folate was S. faecalis-active and 20-35% P. cerevisiae-active. Chromatography of bile folates on TEAE-cellulose showed several folates including four tentatively identified as 10-formyltetrahydrofolate (10-CHO-H4PteGlu), 10-formylfolate (10-CHO-PteGlu), and/or 10-formyldihydrofolate (10-CHOH2PteGlu), methyltetrahydrofolate, and possibly a triglutamate folate. After folate ingestion bile folate concentration increased rapidly. The distribution of bile folates measured by microbiological assay was similar after either folic or folinic acid feeding. Most of the 'H label of folic acid-3H appeared in the biological folates of bile rather than in the folic acid fraction, which shows that the administered folic acid was rapidly transformed to other folates.
Folate polyglutamate deconjugating enzyme activity was found to be much less than in serum. Polyglutamates of the type found in yeast were not found in bile.
It is suggested that biliary folate may reflect the hepatic intracellular oligoglutamate folate pool rather than the folate as it appears in the hepatic portal blood.
INTRODUCTION
The concentration of folate in bile exceeds that in plasma and increases after ingestion of folic acid (1, 2) . The form of the folate in bile is unknown although it recently has been suggested (3) that it is a monoglutamate form different from methyltetrahydrofolate (5-CHs-H4PteGlu), the predominant folate of plasma. Because of evidence suggesting that the form of folate appearing in the portal blood after feeding of folic acid (PteGlu) differs from that following ingestion of 5-formyltetrahydrofolic acid (folinic acid +5-CHOH4PteGlu) or other reduced folates1 (4, 5), we undertook to determine if the pattern of bile folate reflects the form of folate absorbed from the intestine, or if biliary folate might reflect intracellular folate, which thereby provides an indication of the folate of liver cells. In contrast with a previous report (6), we have not observed significant folate deconjugase (conjugase, Y-glutamyl carboxypeptidase) activity in bile.
The pattern of folate activity in serum after feeding folic acid has been interpreted to indicate flushing of methyltetrahydrofolate from tissues followed by slower conversion of ingested folic acid to this coenzyme (4, 7, 8) . We have studied the pattern of folate activity and of 3H appearing in plasma after administration of folic acid-3H and have found these to be consistent with this hypothesis.
METHODS

Assays of folate
Lactobacillus casei assay. The assay method was modified from that described by Baker et al. (9) . Medium was prepared from a commercial mix (folic acid assay; Baltimore Biological Laboratories). Plasma was assayed at a final dilution in the medium of 1: 100, whole blood at 1: 1000, and bile at 1:100 and 1: 1000 dilutions. Initial dilutions of plasma were made in 0.05 M phosphate buffer 'Whitehead, V. M., R. F. Pratt, and B. A. Cooper. 1970 . Human intestinal conversion of folinic acid to 5-methyltetrahydrofolate. To be published.
with ascorbic acid, 150 mg/100 ml at pH 6.0, and 1 ml of these dilutions was added to 9 ml of prepared medium. The method for determining red cell folate has been reported previously (10) . Plasma and whole blood dilutions, but not bile, were autoclaved for 4 min to precipitate proteins, centrifuged, and the supernatants assayed. Culture tubes were autoclaved for 20 min before inoculating with the assay organisms. After 18 hr at 370C, growth of the organisms was compared with that in standard tubes containing 0.1-3.0 ng of folic acid per 10 ml of medium.
Streptococcus faecalis assay. This was based on the method of Teply and Elvehjem (11) (12) (13) . The medium was purchased from Difco (bacto-folic acid assay medium). Plasma was assayed at final dilutions in the medium of 1: 20 and 1: 100, and bile at dilutions of 1: 100 and 1: 1000. Treatment of plasma and bile was the same as that described for the L. casei assay except that the plasma for the 1: 20 dilution was added terminally after autoclaving the medium. The standard curves contained from 1.0 to 10.0 ng of folic acid per 10 ml of medium. As whole plasma was shown to alter the growth of S. faecalis in folic acid, an equivalent volume of fasting plasma was added terminally to a duplicate standard curve so that growth of the cultures containing the 1: 20 plasma dilutions could be assessed more accurately. Pediococcus cerevisiae assay. The method was based on that described in the Difco Manual (12) and by Sauberlich and Baumann (14) . Medium was purchased from Difco (bacto-CF assay medium). The modifications of the basic method for assay of whole plasma were the same as described above for S. faecalis. Standard curves contained from 0.6 to 4.8 ng of DL-folinic acid per 10 ml of medium.
All assays were done in triplicate. After incubation of the inoculated assay media for the appropriate times, the optical densities of the cultures were measured with a colorimeter. The effect of the color of bile was corrected for by subtracting the optical density of a colorimetric blank made by adding an equivalent dilution of bile to uninoculated medium.
Column chromatography
Preparation of folic acid. 3H-labeled folic acid (generally labeled) was purchased from Amersham/Searle (batch No. 20; specific activity 1.6 mCi/mg). Stepwise elution with phosphate buffers from a DEAE-cellulose column was used to purify the folic acid-3H (15) . The specific activity was verified by microbiological assay.
Fractionation of bile. Whole bile could not be chromatographed satisfactorily. Bile dialyzed for 24 hr against 2 volumes of water containing ascorbic acid (150 mg/100 ml) showed equilibration of the folate concentration inside and outside the dialysis bag, whereas 90%o of the bilirubin stayed inside the bag. The entire dialysate was diluted with water so that the electrical conductivity was the same as that of the 0.02 M phosphate starting buffer (conductivity 1800 ,umho). The diluted dialysate was applied to a 1 X 20 cm column containing TEAE-cellulose. Elution was started with enough 0.02 M phosphate buffer, pH 6.7, to make the total volume of bile solution and starting buffer 100 ml, and was followed by 200 ml of 0.1 M phosphate buffer, pH 6.7, and 200 ml of 0.25 M sodium chloride in 0.02 M phosphate buffer, pH 6.7. The flow rate was 1.25 ml/min, and 10-ml fractions were collected. All solutions contained ascorbic acid, 150 mg/100 ml, and collecting tubes contained 0.2 ml of 5% ascorbic acid. The column temperature was 3°C, and the collecting tubes were kept in a bath at 2°C. The fractions were kept refrigerated or frozen at -20°C until assayed. The folate activity of the chromatographed fractions was measured with the three assay organisms by adding 1-9 ml of prepared medium. 1 ml volumes of the eluated fractions were added to counting vials for liquid scintillation counting.
Fractionation of plasma. 5 ml of whole plasma was applied to a TEAE-cellulose column and eluted as for elution of bile. 10-ml fractions were collected. 1 ml aliquots from each fraction were assayed with L. casei and S. faecalis in duplicate, and 1 ml was added to vials for liquid scintillation counting.
Measurement of tritium activity in test solutions
Bile. 0.1 ml of each bile sample was added to 20-ml glass counting vials. One or two drops of 30% hydrogen peroxide were added to decolorize. The volume then was decreased to approximately 0.1 ml by evaporation in air. 0.3-0.5 ml of hydroxide of hyamine 1oX was added, and the vials were allowed to stand 48 hr or more. 1.5 ml of 100% ethanol and 15 ml of toluene scintillator solution were added. Specimens were prepared in duplicate. Plasma. The treatment of plasma was the same as that described for bile except that the decolorizing step was omitted. Efficiency of counting of tritium in plasma or bile was 21-30%o. Column cluate. 15 ml of dioxane scintillator solution was added to 1 ml of each fraction, and the radioactivity was measured as above. The scintillator solution contained 14 g of PPO, 0.6 g of dimethyl POPOP, 200 g of naphthalene, and 1900 ml of dioxane. Studies showed that this solution could hold 1 ml of water or buffer with full recovery of the radioactivity after correction for quenching. Quench correction was accomplished with automatic external standard referred to tritiated water standards quenched with picric acid.
Experimental procedure on patients Eight volunteers, who had had cholecystectomy and common bile duct exploration for gallstones and who had a T tube in the common bile duct, were studied. The studies took place 5 or more days postoperatively when the patients were feeling relatively well and were able to eat. Each patient had been fasting for at least 8 hr on the morning of the study. Bile was drained continuously into the collecting tubes which were changed at 15-or 30-min intervals, covered, and kept on ice until the time of assay. In the last four experiments, 25 mg of ascorbic acid per 15 min of bile collection was added to the tubes prior to the bile collection. Blood for plasma and red cell folate was drawn from an antecubital vein into tubes containing 40 mg of sodium citrate and 10 mg of ascorbic acid for each 10 mg of blood.
After collection of control specimens, 100 ml of a solution containing 1.0 mg of folic acid with tritium content of 20 or 40 ,tCi was given orally to six patients. Com-position of the test solution was verified by 'H counting and folate assay on each occasion. Two other patients received 2.0 mg of DL-5-formyltetrahydrofolate (Leucovorin, Lederle), orally. Blood samples were taken at 30, 60, 90, 120, and 180 min after the oral folate. Bile collecting tubes were changed at 0, 15, 30, 45, 60, 75, 90, 105, 120, 150, and 180 min. Folate content was measured with the three assay organisms, and tritium content was measured as described, which converts the disintegrations per minute to nanograms of folate based on the specific activity of the administered folic acid-3H. At the termination of the folic acid-3H studies, 15 mg of folic acid was given intramuscularly to flush radioactivity into the urine. The folate assays were performed on the day the experiment was done.
In three patients, following the folate absorption study, 15 ,uCi of rose bengal-'I was given intravenously, and bile was collected for 50-90 min to show the rate of appearance of "I. 5-or 10-min collections of bile were placed in counting tubes and counted in a well-type scintillation counter.
Studies on bile polyglutamates and conjugases four at pH 4.6 (0.1 M citrate-phosphate buffer). 1 ml volumes of the reactant substances (bile, serum, or yeast extract solution) were added to buffer containing ascorbic acid, 150 mg/100 ml, to give final volume of 10 ml. Seven incubation solutions were prepared containing the reactants separately or in combinations. The solutions were incubated 90-180 min at 370C. The incubation was ended by placing the tubes in a boiling water bath for 5 min to precipitate proteins. The supernatant solutions were separated by centrifugation and assayed at appropriate dilutions with L. casei. Control solutions were prepared by adding the same reactants to buffer in tubes in the boiling water bath so that enzymes were immediately inactivated. pH of the solutions did not change by more than 0.1 pH unit after adding the reactants to the buffer.
RESULTS
Plasma and bile folates after folic acid-5H ingestion ( Figs. 1 and 2 , Table I ). Plasma and bile folates were followed in five patients after ingestion of 1 mg of folic acid-3H (Table I ). The patterns of plasma and bile folates in all patients were similar. Due to large differences between the bile folate levels in the different patients studied (Table I) Figs. 1 and 2 ). The median values of these studies are plotted in Fig.  1 (top) , and a single representative study of patient 4 is shown in Fig. 2 . Plasma folate rose to a peak 60-90 min after feeding, and then gradually decreased. S. faecalis activity was negligible at time 0, but increased rapidly during the first 30 min, almost paralleling the increase of activity for L. casei. S. faecalis activity then decreased or increased at a slower rate while the L. casei activity continued to increase. No significant P. cerevisiae activity was found in the plasma except on one occasion after feeding folic acid to patient 4. Folate-3H activity increased nearly parallel to S. faecalis activity initially, but by 60-150 min, the folate-3H exceeded the S. faecalis-active folate and then decreased at a rate intermediate between that of S. faecalis and L. casei. These observations are summarized in Fig. 2 (lower) in which the differences between the parameters are plotted. L. casei-S. faecalis activity is assumed to indicate methylfolate concentration, and L. casei-folate-I-to represent nonradioactive or endogenous folate. The shaded area, representing the differences between the two curves, should represent radioactive methylfolate.
Chromatography of plasma taken 30 min after ingestion of folic acid-3H (patients 4 and 6) showed the presence of methyltetrahydrofolate and an L. casei-S. faecalis-active peak at the position of elution of folic acid (fraction 40). However, because of the dilution of folate during chromatography, radioactivity in the fractions was so low that counts were close to background.
Bile folate (Figs. 1 and 3 , Table I ). The total bile folate remained constant or increased slowly in the first 30-45 min after feeding folic acid-3H in all the patients. A marked increase was then seen with elevation of folate to values from 45 to 172 ng/ml between 75 and 120 min after which bile folate concentration gradually decreased. S. faecalis activity in fasting bile was 45-80% of the L. casei activity. After administration of folic acid, the increase of S. faecalis activity was similar to that of L. casei activity in most of the patients. Fasting P. cerevisiae-active folate was 20-35% of the total bile folate. A small increase of P. cerevisiae activity was seen after oral folic acid in three patients, and a larger increase in patients 3 and 6. Folate-3H rise tended to parallel the total folate in three patients, but was less than the increase of folate in patients 3 and 6. The study performed in patient 4 is seen in Fig. 3 .
Effect of feeding 5-formyltetrahydrofolate on plasma and bile folates (Fig. 4 , Table II ). Plasma and bile folates were measured in two patients after feeding 2 mg of DL-5-formyltetrahydrofolate a quantity equivalent in biological activity to the folic acid given to the other patients. The effect of this folate on plasma and bile folates was similar in the two patients; the mean values are plotted in Fig. 4 . Most of the early rise of total plasma folate was due to folate active only for L. casei suggesting that the 5-formyltetrahydrofolate was more rapidly transformed to methyltetrahydrofolate than was folic acid. However, the appearance of some S. faecalisand P. cerevisiae-active folate at 30 min suggests that some 5-formyltetrahydrofolate had been absorbed. Chromatography on TEAE-cellulose of serum taken after orally administered 5-formyltetrahydrofolate showed this folate to elute in the position of 5-formyltetrahydrofolate.' Changes in bile folate were similar to those found after administration of folic acid (Fig. 4) . The absence of a large increase of P. cerevisiae activity suggests that little or no 5-formyltetrahydrofolate, a relatively stable folate, appeared in the bile.
Correction for delay in sampling of bile (Fig. 5) . The rate of flow of bile out of the T tube was 0.25 to 0.4 ml/ min. To calculate the delay between the presentation of the folate to the liver and its appearance in the bile, rose bengal-Y1'I was injected intravenously in three patients immediately after bile collection for folate. This material, which is rapidly excreted into the bile (16) , appeared in the T-tube effluent 15-20 min after injection, and reached a maximum at 50-60 min. The study of patient 7 is seen in Fig. 5 . It would appear that bile folate concentration increased about 10 min after the appearance of rose bengal-31I, which suggests that the first folate increment was presented to the liver cell no more than 10 min after feeding. The peak concentration of folate was seen 55 min after the rose bengal--uI peak. Chromatography of dialysates of bile (Figs. 6 and 7) . Dialysates of bile from patients 4, 5, 6, and 8 were chromatographed on TEAE-cellulose. Fig. 6 shows the A similar study is shown in Fig. 7, a Fig. 7 to that of te and rose fasting bile in Fig. 6 , except that a folate eluted at fracis the folate tion 40 of Fig. 7 which supported growth of L. casei and ren orally to S. faecalis but not P. cerevisiae. This is the position of in bile after elution of folic acid. It is apparent that 3H activity apimmediately peared in most of the fractions, which indicates incorporation of the administered folic acid-8H into several different folates. The earliest Studies on bile polyglutarnate folates and deconjugases rted growth (Table III) . Table III After feeding folic acid-3H, most of the initial increment of plasma folate was due to a 3H-labeled folate active for L. casei and S. faecalis but not P. cerevisiae. TEAE-cellulose chromatography of plasma showed that this folate had the mobility and microbiological activity of folic acid, but the radioactivity in the plasma was too low to confirm that the radioactivity was present in this folate fraction. This early appearing folate probably was folic acid. During the 1st hr after feeding the folic acid-31H, an increase was observed in the L. casei-active, S. faecalis-negative fraction of total plasma folate which is presumed to be methyltetrahydrofolate. This was unassociated with an increase of tritium above the level accounted for by the folic acid fraction. After the 1st hr, the 3H activity decreased more slowly than did the S. faecalis activity, which indicates that some of the 3H-labeled material no longer supported growth of S. faecalis and was either converted to a form which would support only L. casei (i.e., methyltetrahydrofolate) or to a microbiologically inactive form. The simplest explanation for these observations is absorption of unaltered folic acid-3H into the plasma together with flushing of nonradioactive methyltetrahydrofolate from the tissues, followed by conversion of some of the folic acid-3H to methyltetrahydrofolate-3H. It is probable that all of the 8H remained associated with folate since folic acid-3H has been found to be stable in serum for 3 hr in vitro (17) . We have not excluded, however, the possibility that some of the 3H activity in plasma was associated with a breakdown product such as para-aminobenzoyl glutamate.
Previous findings (1, 2) of high folate in bile have been confirmed. Unlike plasma folate, only 20-55% of bile folate was methylfolate. The evidence presented sug- Some of the administered folic acid was excreted unchanged into the bile, but most of it was transformed into biological folates. Considering the time taken for secreted bile to be sampled, the increase of bile folate concentration was rapid after folic acid administration. 5-Formyltetrahydrofolate was much more rapidly transformed to methyltetrahydrofolate than was folic acid after oral administration. This agrees with findings reported by Perry and Chanarin (5) . A small proportion of the administered 5-formyltetrahydrofolate, however, did reach the peripheral circulation. The bile folates after 5-formyltetrahydrofolate feeding were similar to those after administration of folic acid.
Bile contained very little, or no, folate deconjugase activity by the assay method used here. This method is qualitative, but shows that bile contains less than 4% of the conjugase activity of an equivalent volume of serum. This observation disagrees with that of Bernstein and Gutstein (6) who reported extremely high levels of deconjugase in rat bile and human T tube bile. The reason for this disagreement is not apparent and may depend on differences of assay conditions. However, the 4.6 pH used was in the range that they recommended. Expression of deconjugase activity as folate released per milligram of protein rather than per milliliter of plasma or bile would make the bile deconjugase activity appear relatively higher. Addition of serum deconjugase to bile caused little or no increase of folate activity, which suggests that significant quantities of folate polyglutamates of the type found in yeast were not present in bile.
The finding that there are several different folates in bile, that 3H appears rapidly in these folates after folic acid-3H administration, and that the folates in bile are similar after either folic or 5-formyltetrahydrofolate acid feeding is consistent with the supposition that bile folates reflect the intracellular oligoglutamate folates of liver rather than being the excretion of a proportion of the folate presented to the liver by the portal venous blood. Studies of the rate of appearance of label in bile folates may provide a useful tool for an in vivo investigation of the transport of folates into liver and their metabolic interconversion.
